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Over the past decade, a vast array of nanomaterials has been created through the devel-
opment of nanotechnology. With the increasing application of these nanomaterials in 
various fields, such as foods, cosmetics, and medicines, there has been concern about 
their safety, that is, nanotoxicity. Therefore, there is an urgent need to collect information 
about the biological effects of nanomaterials so that we can exploit their potential bene-
fits and design safer nanomaterials, while avoiding nanotoxicity as a result of inhalation 
or skin exposure. In particular, the immunomodulating effect of nanomaterials is one 
of most interesting aspects of nanotoxicity. However, the immunomodulating effects of 
nanomaterials through skin exposure have not been adequately discussed compared 
with the effects of inhalation exposure, because skin penetration by nanomaterials is 
thought to be extremely low under normal conditions. On the other hand, the immuno-
modulatory effects of nanomaterials via skin may cause severe problems for people with 
impaired skin barrier function, because some nanomaterials could penetrate the deep 
layers of their allergic or damaged skin. In addition, some studies, including ours, have 
shown that nanomaterials could exhibit significant immunomodulating effects even if 
they do not penetrate the skin. In this review, we summarize our current knowledge of 
the allergic responses induced by nanomaterials upon skin exposure. First, we discuss 
nanomaterial penetration of the intact or impaired skin barrier. Next, we describe the 
immunomodulating effects of nanomaterials, focusing on the sensitization potential of 
nanomaterials and the effects of co-exposure of nanomaterials with substances such 
as chemical sensitizers or allergens, on the onset of allergy, following skin exposure. 
Finally, we discuss the potential mechanisms underlying the immunomodulating effects 
of nanomaterials by describing the involvement of the protein corona in the interaction 
of nanomaterials with biological components and by presenting recent data about the 
adjuvant effects of well-characterized particle adjuvant, aluminum salt, as an example of 
immunomodulatory particulate.
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iNTRODUCTiON
Recently, advances in nanotechnology have made possible the 
design and production of many engineered nanomaterials—
nanoparticles, nanofibers, and nanosheets—which are defined as 
materials with structures having at least one dimension less than 
100 nm (1, 2). These products have become indispensable in vari-
ous fields, such as electronics, foods, cosmetics, and medicines, 
because nanomaterials have unique physicochemical properties 
and exert innovative functions compared with conventional 
larger particles; these properties and functions include enhanced 
electrical conductivity, tensile strength, and chemical reactivity, 
and stem from an increase in the surface area per unit weight 
compared with a larger amount (>100 nm) of the same material 
(3, 4). However, with the increasing use of nanomaterials, con-
cerns about their safety, termed nanotoxicity, have been raised, 
specifically that the innovative functions of nanomaterials, such 
as high chemical reactivity and high tissue penetration, due to 
their small size might make them hazardous in some situations 
(5, 6). For example, our group has shown that intravenous injec-
tion of a large amount of silica (SiO2) nanoparticles induced 
pregnancy complications in mice, although it should be noted 
that the level of exposure used in the study is not representative 
of real-world human exposure (7). The health risks of engineered 
nanomaterials to humans have also been considered (8–10). 
Among the nanotoxic effects, those on host immunity are of 
particular interest, because the immune cells recognize foreign 
substances as part of the body’s defenses, when those substances 
enter the body. Therefore, there have been many reports about the 
immunomodulating effects, both immune-activating and -sup-
pressing effects, of nanomaterials in vitro and in vivo (11–13). To 
fully utilize the potential benefits of nanomaterials and design 
safer nanomaterials, it is essential for us to collect more informa-
tion about nanotoxicity, because intentional and unintentional 
exposure to nanomaterials is unavoidable in our everyday life.
Our skin is exposed to nanomaterials in many situations, 
because nanomaterials are contained in cosmetics and other 
skincare products. For example, some nanoparticles, especially 
Zinc oxide (ZnO) and titanium dioxide (TiO2) nanoparticles, 
have been used in sunscreens since the 1980s, because they have 
better ultraviolet (UV) protective properties than larger particles 
(14). SiO2 nanoparticles are used in a wide variety of cosmetics 
as an anti-setting agent (15). We are also exposed to silver (Ag) 
nanoparticles through our everyday lives because Ag nanopar-
ticles have been widely applied to consumer products such as 
clothing, antibacterial sprays, detergent, socks, and shoes for 
antimicrobial purposes (16). Therefore, an understanding of the 
absorption rate of nanomaterials after exposure via the skin has 
attracted increasing attention over the past few years, because it 
is important to consider the immunomodulatory effects of nano-
materials on the skin. In addition, because nanomaterials can 
interact with other substances easily (17), we must not forget that 
exposure to nanomaterials via skin often occurs simultaneously 
with exposure to other chemical compounds and allergens, such 
as foods and pollen and that this interaction might modulate the 
antigenicity of these compounds. Many recent reports have shown 
that skin is an important site for the onset of allergy (18, 19). For 
example, several reports have shown that transdermal exposure 
to food allergens can induce Th2-type immune responses and 
be sufficient to sensitize mice (20–22). Furthermore, individu-
als who used a facial soap containing hydrolyzed wheat protein 
were presumed to be sensitized to this protein (23, 24). Given 
these findings, there is an urgent need to understand the immu-
nomodulatory effects of nanomaterials upon skin exposure, 
particularly effects that may lead to the onset or aggravation of 
allergy. However, while there have been many studies examining 
the nanotoxicity of nanomaterials to the respiratory system, there 
is a lack of knowledge about nanotoxicity following skin exposure 
to nanomaterials, especially the immunomodulating effects.
In this review, we summarize our current understanding of 
the skin penetration of nanomaterials and the immunomodulat-
ing effects of nanomaterials, focusing on the skin penetration of 
nanomaterials, the sensitization potential of nanomaterials, and 
the effects of co-exposure of nanomaterials with allergens on 
the onset of allergy upon skin exposure. In addition, we discuss 
potential mechanisms underlying the immunomodulating effects 
of nanomaterials by describing the involvement of the protein 
corona in the interaction of nanomaterials with complement 
proteins and by presenting recent study about the adjuvant 
effects of aluminum salts, which are well characterized in basic 
immunology.
SKiN STRUCTURe AND PeNeTRATiON OF 
SKiN BY NANOMATeRiALS
The skin is composed of several barriers that prevent foreign 
substances from penetrating the body (25, 26). Healthy skin is 
divided into the epidermis and the dermis. In addition, there 
are two physical barriers in the epidermis: the stratum corneum, 
the outmost layer of the epidermis, and tight junctions, which 
are intercellular junctions that seal adjacent keratinocytes in the 
stratum granulosum below the stratum corneum (25, 26). It is 
generally believed that molecules, other than small lipophilic 
molecules (<500 Da), are unable to penetrate healthy skin due to 
these barrier functions (27). The skin also contains hair follicles 
and sebaceous glands (28). Hair follicles extend into the dermis 
and might provide a means for penetration and absorption of 
compounds into the skin. Therefore, hair follicles may play an 
important role as a potential reservoir and penetration route 
for topically applied substances. It is also suggested that hair 
follicles have important functions in immune responses such 
as those regulating the trafficking of antigen presenting cells 
(29). In addition, many immune cells such as antigen presenting 
cells [e.g., Langerhans cells (LCs) in the epidermis and dermal 
dendritic cells in the dermis] and leukocytes are present in the 
skin to protect the body from external substances (30). Recently, 
tape stripping of murine skin showed that activated LCs could 
elongate their dendrites above the tight junctions of keratinocytes 
and take up antigens on the surface of the skin (31, 32).
Whether nanomaterials can penetrate the skin barrier in vivo 
remains controversial, although there have been several reports 
assessing the skin penetration of nanomaterials after topical 
application using both in  vitro and in  vivo models (Figure  1). 
FigURe 1 | Penetration of skin by nanomaterials. After topical 
application to healthy skin, nanomaterials may penetrate to the stratum 
corneum or epidermis. However, after application to allergic or damaged 
skin, nanomaterials may penetrate to the epidermis and dermis.
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Because TiO2 and ZnO nanoparticles are essential components 
in sunscreens, many studies have examined the penetration rate 
of these nanoparticles, although it should be noted that these 
nanoparticles are typically present in sunscreens as 30- to 150-nm 
aggregates. Cross et  al. and Larese et  al. have shown that ZnO 
nanoparticles with diameters of 15–40 nm, and Ag nanoparticles 
with a diameter of 25 nm, can penetrate the upper layers of the 
stratum corneum but cannot reach the deeper layers of the viable 
epidermis and dermis by using an in vitro model of human skin 
(33, 34). Lin et  al. also showed that ZnO nanoparticles with a 
diameter of 10–50 nm could not penetrate healthy skin or tape-
stripped skin of human volunteers (35). These reports suggest 
that the stratum corneum and tight junctions of skin provide an 
effective barrier to prevent nanomaterial penetration of healthy 
skin. In contrast, Gulson et al. have shown that small amounts of 
ZnO nanoparticles with a diameter of 19 nm can penetrate the 
skin after repeated application to healthy humans (36, 37). These 
results suggest that nanomaterials may penetrate the skin after 
repeated application to even healthy skin (Figure 1). However, 
these different results might be due to differences in the analytical 
methods used, in the detection sensitivity of the analytical meth-
ods, in the sample volume or skin model used, or in the type of 
nanomaterials and their aggregation state. For example, although 
Gulson et  al. used ZnO particles containing the stable isotope 
68Zn and were able to detect the concentration of 68Zn in the body 
at high sensitivity (36, 37), other groups used conventional nano-
materials and transmission electron microscopy and inductively 
coupled plasma mass spectrometry techniques in their studies 
(33–35). In addition, although transmission electron microscopy 
and mass spectrometry techniques are useful for evaluating the 
penetration of skin by nanomaterials, transmission electron 
microscopy is a qualitative method that cannot be used to deter-
mine the amount of nanomaterials in the skin, and inductively 
coupled plasma mass spectrometry is a quantitative method that 
cannot distinguish between nanomaterials and their dissociated 
ions. Therefore, the development of more sensitive qualitative and 
quantitative analysis methods is an important step in elucidating 
the penetration of nanomaterials through the skin.
The skin barrier is not always intact because skin is under 
constant assault every day by mechanical irritation, mechanical 
damage (cuts or scrapes), UV exposure, microbial pathogens, 
and the use of harsh soaps or cosmetic products that may contain 
chemical irritants (25). In addition, people with healthy skin and 
those with impaired skin barrier function apply sunscreens con-
taining nanomaterials. In this regard, some studies have exam-
ined whether nanomaterials can penetrate deeply into allergic or 
damaged skin because nanomaterials may be able to penetrate 
skin with impaired barrier function. Ilves et al. showed that ZnO 
nanoparticles with a diameter of 20  nm could be observed in 
the epidermis and to a lesser extent also in the dermis of allergic 
skin of mice after topical application, but ZnO particles with a 
diameter of 240 nm were not detected (38). Similar to their obser-
vations, other studies using human skin explants with partially 
disrupted stratum corneum have shown that 40-nm polystyrene 
nanoparticles, but not 750- or 1500, and 40-nm SiO2 nanoparti-
cles can translocate to the viable epidermis (39, 40). In addition, 
Mortensen et al. showed that quantum dot nanoparticles with a 
diameter of 45 nm could penetrate deep into the epidermis and 
dermis in sub-erythemal dose UV radiation-exposed mice (41). 
These reports suggest that nanomaterials generally can penetrate 
the deep layers of the skin, such as the epidermis and the dermis 
of allergic or damaged skin (Figure  1). Although the precise 
number of penetrated nanoparticles needs to be quantified, these 
findings emphasize the importance of investigating the immu-
nomodulatory effects of nanomaterials after topical application.
Recently, hair follicles have been considered an excellent target 
route for drug delivery via skin (42). Many researchers have tried 
to deliver drug compounds via hair follicles by using particles 
such as liposomes (42, 43). Hair follicles have the potential to be 
efficient, long-term reservoirs suited for accumulation of nano-
materials. Therefore, the hair follicular pathway may be one of 
the penetration pathways of nanomaterials, although it remains 
largely unknown whether nanomaterials can indeed penetrate 
the skin via hair follicles (44, 45).
SeNSiTiZATiON POTeNTiAL OF 
NANOMATeRiALS ON SKiN
Allergic contact dermatitis induced by chemicals is the most 
frequent manifestation of skin sensitization in humans (46). It is 
estimated that about 4,000 chemicals have the potential to be skin 
sensitizers (47). Because sensitization to chemicals is sometimes 
induced at relatively low levels of exposure to that substance via 
skin exposure, the sensitization potential of nanomaterials might 
be an important potential nanotoxicity.
Park et  al. showed that neither amine-modified polystyrene 
nanoparticles with a dimeter of 50  nm nor TiO2 nanoparticles 
(primary size <25  nm) induced skin sensitization after topical 
skin treatment, as assessed using a local lymph node assay (LLNA), 
which is a useful method for evaluating the sensitization potential 
of chemicals (48). Lee et al. evaluated the sensitization potential 
FigURe 2 | Metal nanoparticles as a potential trigger of metal allergy. 
Metal-based fashion accessories may expose the wearer to metal ions that 
generate metal nanoparticles. These metal nanoparticles are then 
translocated to the lymph nodes where they release metal ions that induce 
metal ion-specific CD4+ T cells and IL-17-mediated immune responses.
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of two types of SiO2 nanoparticles, mesoporous SiO2, and col-
loidal SiO2, with diameters of about 100 nm (49). Changes in ear 
skin thickness after painting the skin with each nanoparticle for 
three consecutive days were small. In addition, these authors also 
found that neither nanoparticle induced skin sensitization, as 
assessed using a LLNA. These results suggest that the sensitiza-
tion potential of many nanomaterials after topical application to 
healthy skin might be low. Skin painting is a typical method used 
to analyze the sensitization potential of chemical compounds, but 
nanomaterials do not easily penetrate healthy skin. Therefore, 
subcutaneous or intradermal administration might be useful as 
alternative routes for examining the sensitization potential of 
nanomaterials, assuming that the particles are able to penetrate 
allergic or damaged skin.
Epidemiological studies have suggested that sensitizer metals 
contained in airborne particulates may also contribute to the 
onset of metal allergy (50–52). Since metal nanoparticles can 
release metal ions, we must pay attention to the sensitization 
potential of not only nanoparticles but also metal ions released 
from metal nanoparticles. Metal allergy, which is a major cause 
of allergic contact dermatitis, is prevalent in the general popula-
tion, and up to 17% of women are reported to suffer from it (53, 
54). Nickel is the most frequent cause of metal allergy, but gold, 
palladium, cobalt, mercury, beryllium, chromium, and silver 
also have sensitization potential (54). It is suggested that metal 
ions from jewelry and clothes (buttons, zippers, and belt buckles) 
cause metal allergy via the activation of innate and adaptive 
immunity. Although it is believed that metal allergy is caused by 
metal-ion-induced T cells, which are generally reactive to metal 
ions in the major histocompatibility complex, many attempts to 
sensitize mice by means of simple metal-ion treatment have failed 
(55, 56). Moreover, while some reports have shown that metal 
allergy in mice can be induced by concomitant application of 
inflammatory stimuli, such as lipopolysaccharide (LPS) (57, 58), 
the skin reactions in these models could be induced by irritant 
inflammation rather than allergic responses (59). Nevertheless, 
these studies raised the possibility that other unknown factors 
may contribute to the onset of metal allergy.
Recently, it was revealed that metal nanoparticles are gener-
ated in the environment and in our bodies naturally during our 
daily lives (60). For example, Glover et  al. showed that metal 
nanoparticles were generated spontaneously from manmade 
objects such as earrings or metal wire, suggesting that macroscale 
metal objects might be a potential source of naturally occurring 
nanoparticles in the environment (61). In addition, naturally 
occurring metal nanoparticles are thought to be formed from 
ions via chemical and/or photochemical reduction of released 
metal ions from metal objects (61, 62). Therefore, we could be 
extemporaneously exposed to metal ions from metal objects when 
we wear metal accessories and then these ions could generate 
naturally occurring metal nanoparticles when we are sensitized 
to metal. In this regard, our group examined the contribution 
of metal nanoparticles to the onset of metal allergy by using Ag 
nanoparticles or nickel (Ni) nanoparticles with several kinds of 
diameters (63) (Figure 2). We showed that mice sensitized with Ag 
nanoparticles or nickel nanoparticles plus LPS exposure, but not 
with metal ions, experienced allergic inflammation in response to 
both metal ions and metal nanoparticles in the elicitation phase. 
We also showed that LPS was necessary for sensitization to metal 
nanoparticles. However, gold and SiO2 nanoparticles, which 
are minimally ionizable, did not induce allergic inflammation, 
even when co-administered with LPS. In addition, smaller metal 
nanoparticles had stronger sensitization potential than larger 
ones. We observed that CD4+ T cells were required for immune 
responses induced by metal nanoparticles and IL-17A-mediated 
inflammation was responsible for the allergic responses. On the 
basis of this study, we suggested that metal nanoparticles might 
play a role as a carrier, conveying metal ions to the lymph nodes 
for metal sensitization, because we found that smaller metal 
nanoparticles were transferred to the draining lymph nodes 
more readily than larger metal nanoparticles and metal ions. This 
study identifies metal nanoparticles as a new potential trigger of 
metal allergy and highlights the need to pay close attention to 
the indirect sensitization potential of metal nanoparticles when 
evaluating their safety.
COMBiNeD eXPOSURe TO 
NANOMATeRiALS AND OTHeR 
SUBSTANCeS
Our skin is often exposed to nanomaterials simultaneously with 
other chemical compounds and allergens, such as foods and pol-
len. Therefore, it is important to examine the possibility that skin 
exposure to nanomaterials contributes to allergen-induced onset 
of allergy.
Allergic contact dermatitis is generally induced by a chemical 
sensitizer. Hussain et al. showed the effect of TiO2 nanoparticles 
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with a diameter of 22 nm on the sensitization potential of dini-
trochlorobenzene (DNCB), a well-known skin sensitizer (64). 
They showed that subcutaneous injection of TiO2 nanoparticles 
before DNCB treatment increased DNCB-mediated lymph 
node proliferation in an LLNA and enhanced Th2-type cytokine 
production, whereas TiO2 nanoparticles alone showed no dermal 
sensitization. This study suggests that some nanomaterials can 
enhance the sensitization potential of chemical sensitizers when 
they penetrate the skin. Moreover, several reports have shown 
that topical application of nanomaterials also has an effect on skin 
sensitization caused by chemicals. Lee et al. showed that 3 days 
of consecutive skin painting with mesoporous SiO2 nanoparticles 
with a diameter of about 100 nm and 2,4-dinitroflourobenzene 
(DNFB) exacerbated DNFB-induced ear skin thickness and 
lymphocyte proliferation (49). Smulders et  al. compared the 
effect of different topically applied nanoparticles (TiO2, Ag, and 
SiO2 nanoparticles) on DNCB-induced dermal sensitization 
by an LLNA (65). They showed that only TiO2 nanoparticles 
enhanced sensitization to DNCB by augmenting a Th2 response. 
Together, these reports demonstrate that some nanomaterials can 
enhance the potential of chemical sensitizers after either topical 
application or intradermal/subcutaneous injection, although 
the physiochemical properties of the nanomaterials (e.g., size, 
shape, composition, charge, and surface energy) might influence 
the effects. Further studies are needed to reveal the mechanisms 
behind these nanomaterial effects and to identify the threshold 
amounts that are hazardous.
It is estimated that 15–30% of children and 2–10% of adults 
suffer from atopic dermatitis (66). Atopic dermatitis is believed 
to progress to allergic rhinitis and asthma over time, which is 
referred to as the atopic march. Of note, the incidence of atopic 
dermatitis has increased gradually in industrialized countries (67, 
68). Some reports have shown that co-exposure to nanomaterials 
and protein allergens affect atopic allergy. Yanagisawa et al. showed 
that intradermal injection of TiO2 nanoparticles of different sizes 
(15, 50, or 100 nm) together with mite allergen, which is a major 
cause of atopic dermatitis, enhanced atopic dermatitis-like skin 
lesions and Th2-type cytokine production, as well as total IgE and 
histamine levels in serum (69). They observed that the size of 
the TiO2 nanoparticles did not influence these effects. They also 
observed similar effects in NC/Nga mice treated with polystyrene 
nanoparticles (70). In this case, enhancement of allergic responses 
was totally depended on the size of particle, that is, the smaller 
polystyrene nanoparticles induced greater symptoms. We also 
investigated the co-exposure effects of SiO2 particles of different 
sizes (30, 70, 100, 300, or 1000 nm) and mite antigen on atopic 
dermatitis in NC/Nga mice (71), and found that intradermal 
exposure of SiO2 particles and mite antigen aggravated atopic 
dermatitis. This effect was correlated with excessive induction 
of total IgE and stronger systemic Th2 responses. Of note, the 
aggravating effects were more pronounced in the smaller SiO2 
nanoparticle-injected mice than in the mice exposed to the larger 
particles.
Other reports have shown the effects of nanomaterials on atopic 
dermatitis after topical skin painting. Ilves et  al. used a mouse 
model of atopic dermatitis and showed that ZnO nanoparticles 
with a diameter of 20 nm cause an increase in IgE production 
after repeated topical application. However, these nanoparticles 
decreased local skin inflammatory responses, such as cytokine 
induction, in this mouse model (38). Our group showed that topi-
cal skin painting with a mixture of SiO2 nanoparticles and mite 
allergen suppressed allergen-specific IgG production without 
any changes in the IgE and Th1/Th2 immune responses (72). 
In addition, the suppression of IgG caused severe IgE-mediated 
hypersensitivity in an anaphylaxis model. Interestingly, low-level 
IgG production was induced when the mice were exposed to 
allergen-SiO2 nanoparticle agglomerates, but not when the 
mice were exposed to nanoparticles applied separately from 
the allergen, to well-dispersed nanoparticles, or to nanoparticle 
agglomerates via routes other than the skin. Thus, agglomera-
tion of the allergen and SiO2 nanoparticles may have created a 
“depot” effect that could control the concentration of the exposed 
allergen and prolong allergen exposure. Thereby, we suggest that 
allergen-SiO2 nanoparticle agglomerates facilitated IgE-biased 
allergic sensitization.
These reports suggest that any nanomaterials could control the 
immune responses induced by a chemical sensitizer or allergen 
on the skin of humans. However, the mechanism responsible 
for these effects remains unclear. In the study described above, 
Smulders et al. observed that titanium levels were increased in 
lymph node cells after topical application of TiO2 nanoparticles, 
indicating that TiO2 nanoparticles penetrated the skin and trans-
located to the lymph nodes (65). We know that nanomaterials 
(<100 nm) can move to the draining lymph nodes via lymphatic 
vessels, but larger particles become trapped in the tissue and tend 
to depot near the site of injection (73). Winter et al. showed that 
TiO2 and SiO2 nanoparticles induce the activation of murine 
dendritic cells in vitro by upregulating co-stimulatory molecules 
(74). Therefore, one of the immunomodulating mechanisms of 
nanomaterials might be that they move to the draining lymph 
nodes after topical application and activate dendritic cells in the 
lymph nodes. However, little is understood about how nanomate-
rials affect the function of immune cells such as LCs and γδ T cells 
in the skin. In addition, as mentioned earlier, hair follicles have 
recently been revealed to have important functions in regulat-
ing the trafficking of LCs and skin-resident memory T cells (29, 
75), and nanomaterials are prone to accumulate in hair follicles. 
Future studies should include detailed investigations into the 
relationship between the qualitative and quantitative distribution 
of nanomaterials in the skin and the effects of nanomaterials on 
skin immune cells, keratinocytes, and hair follicles.
We also must pay attention to the interaction of nanomaterials 
with antigens. Nanomaterials can bind more antigen per mass 
unit than larger particles, because nanomaterials have a larger 
per unit surface area per mass than larger particles. This leads 
to an enhancement of antigen persistence and prolonged release, 
an effect referred to as the “depot effect.” It has been suggested 
that smaller TiO2 nanoparticles bind more protein antigen per 
mass unit than larger ones and that the depot effect on the anti-
gen due to this binding may lead to increased antigenicity (76). 
Furthermore, as described below, one of the immune-activating 
mechanisms of aluminum salts, which are a well-known vac-
cine adjuvant, is believed to involve the depot effect. Therefore, 
the depot effect might also be one of the immune-enhancing 
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mechanisms of nanomaterials, particularly when co-exposed 
with antigens.
As noted earlier, our study showed that the depot effect by 
allergen–SiO2 nanoparticle agglomerates might modulate the 
exposure level of allergens on the skin and could change the 
immune responses, even though these allergen–SiO2 nanoparti-
cle agglomerates could not penetrate the skin (72). In fact, our 
group found that differences in the cutaneous exposure level of 
allergens modulates the level of allergen-specific IgG and affects 
susceptibility to the IgE-mediated allergic response observed in 
other report (77). Therefore, allergen–nanomaterial aggregates 
and agglomerates might modulate immune responses via per-
sistent release of allergen, even though the complexes are not 
able to penetrate the stratum corneum or tight junctions of the 
epidermis. These results suggest that we must examine several 
types of depot effects of complexes between nanomaterials and 
allergens.
THe PROTeiN CORONA, 
NANOMATeRiALS, AND COMPLeMeNT
As described above, it is important to pay attention to the binding 
of compounds with nanomaterials. It is generally understood that 
nanomaterials could interact with proteins and other biomol-
ecules contained in a biological fluid, when nanomaterials enter 
a biological fluid such as blood. For example, proteins bind to 
nanomaterials to form a coating around the surface known as 
the protein corona; when nanomaterials are mixed with plasma, 
the protein corona forms rapidly (within 30 seconds) (78). The 
protein composition of the corona does not seem to change mark-
edly over time, although the concentration of a specific protein 
in the corona may change (78). Therefore, we must consider the 
possibility that the protein corona is involved in one or more of 
the mechanisms underlying the immunomodulating effects of 
nanomaterials.
The formation of the protein corona is an important factor that 
determines the interactions of nanomaterials with cells. Lesniak 
et al. reported that the protein corona surrounding nanomateri-
als inhibits the adhesion of nanomaterials to the cell membrane, 
resulting in a low internalization efficiency (79). In addition, they 
showed that the protein corona modulates not only the amount 
of nanomaterial taken up into cells but also the intracellular 
localization of nanomaterials within cells. Furthermore, detailed 
examination of the proteins within the corona has suggested 
that not all proteins in the protein corona modulate the cellular 
uptake of nanomaterials. For example, Deng et  al. showed in 
in vitro studies that negatively charged gold nanoparticles bind 
to fibrinogen (80), and that the interaction of gold nanoparticles 
with fibrinogen induces fibrinogen unfolding, which promotes an 
interaction with the integrin receptor, Mac-1, which is expressed 
on macrophages. The binding and activation of Mac-1 induces 
inflammatory responses in macrophages. Therefore, the protein 
corona might contribute to the immunomodulatory effects of 
some nanomaterials. Indeed, if the protein corona of nanoparti-
cles contains complement and coagulation factors, it can induce 
complement activation and blood clotting followed by unwanted 
inflammatory responses (81–84). The complement system not 
only works as an innate immune sensor but also plays an essential 
role as a trigger for inducing adaptive immunity. Although few 
studies have examined whether the protein corona containing 
complement proteins could contribute to the immunomodulatory 
effects of nanomaterials, some studies have suggested strategies 
involving the use of complement activation by nanomaterials as 
an adjuvant for vaccines (85, 86). Reddy et al. designed pluronic-
stabilized polypropylene sulfide nanoparticles with a diameter 
of 25  nm that could strongly activate complement (85). They 
showed that the nanoparticle-conjugated antigen could induce 
antigen-specific immune responses. In the future, the effects of 
complement activation by nanomaterials on the onset of allergic 
responses should be investigated. In addition, few studies have 
systemically examined the relationship between the activation 
of complement and the surface properties of particles, because 
protein binding, including complement binding to nanomateri-
als, is known to depend on the physicality of nanomaterials, 
such as their size and surface properties (87). Elucidation of the 
fundamental rules that govern complement recognition of nano-
materials could help us to better predict the immunomodulatory 
effects of nanomaterials in the future.
iMMUNOMODULATiNg MeCHANiSMS OF 
THe ADJUvANT eFFeCTS OF PARTiCLeS
As described above, many nanomaterials have been reported to 
have the potential to enhance adaptive immunity, that is, they 
have adjuvant effects. However, the molecular mechanisms of 
the adjuvanticity of nanomaterials remain largely unknown. 
Many particles besides nanomaterials have been reported to have 
adjuvant effects, such as hemozoin, which is a heme metabolite 
during malaria infection, chitin particles from fungal cell walls, 
and monosodium urate crystals released from damaged cells 
(88–90). Aluminum salt is a well-known particle adjuvant that 
is widely used throughout the world as an adjuvant for human 
vaccines (91). Since aluminum salts are the most studied particle 
with adjuvant effects, we will introduce aluminum salts as a typi-
cal example to summarize the mechanism of adjuvant effects in 
the context of the immunomodulatory effects of nanomaterials.
About one century ago, the usefulness of aluminum, in its 
potassium salt form, as a vaccine adjuvant was described for 
the first time (92). Since this report, several reports have shown 
the adjuvant effects of aluminum salts, especially aluminum 
oxyhydroxide, because aluminum salts induce strong antigen-
specific Th2 immune responses such as the production of IL-4 
and IL-5 and the induction of IgE and IgG1. Nowadays, many 
vaccines formulated with aluminum salts, such as the diphtheria-
tetanus-pertussis vaccine, the pneumococcal conjugate vaccine, 
and hepatitis B vaccine, are approved by the US Food and Drug 
Administration (93). Recently, progress was made in revealing 
the mode of action of aluminum salts, although a large part of the 
adjuvant mechanism remains unclear.
The surface charge of aluminum salts is positive at physiologi-
cal pH and aluminum salts can bind to negatively charged com-
pounds, including protein antigens (94, 95). Therefore, the depot 
effect is thought to play a part in the adjuvanticity of aluminum 
salts. However, some studies have questioned the importance of 
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depot effects in the adjuvanticity of aluminum salts (96–98). For 
example, Hutchison et  al. showed that surgical removal of the 
injection site 2 hours after co-administration of antigen and alu-
minum salts had no effect on antigen-specific immune responses 
in mice (96). Thus, it may be that aluminum salts have additional 
effects that contribute to their adjuvanticity, with the depot effect 
being just one of the underlying mechanisms.
The NLRP3 inflammasome is gaining attention for its role 
in the initial stages of inflammation, such as the production of 
IL-1β and IL-18, which are generated in response to a number 
of diverse particles, including monosodium urate crystal, silica, 
asbestos, and aluminum salts (99–101). Some reports have shown 
that aluminum salts induce antigen-specific IgG1 responses 
that are dependent on the NLRP3 inflammasome (101, 102), 
although other reports suggest that the NLRP3 inflammasome is 
not required for the adjuvanticity of aluminum salts (103, 104). 
This discrepancy might stem from differences in the aluminum 
salts (Imject alum (101, 102) or aluminum hydroxide (103, 
104)) or mice (C57BL/6 (101, 102, 104) or mixed C57BL/6–129 
(103)) used in the studies, and the importance of the NLRP3 
inflammasome for the adjuvanticity of aluminum salts remains 
controversial. Recently, it was revealed that several types of nano-
materials induce NLRP3 activation (105). For example, Simard 
et al. showed in vitro that Ag nanoparticles activate the NLRP3 
inflammasome by inducing the degradation of the ER stress 
sensor ATF-6 (106). In addition, Sun et al. showed that NADPH 
oxidase-dependent NLRP3 inflammasome activation is crucial 
for the lung fibrosis induced by multiwalled carbon nanotubes 
(107). However, few studies have investigated the link between 
the activation of the NLRP3 inflammasome by nanomaterials and 
the induction of adaptive immunity. Detailed studies to test this 
hypothesis are expected.
Recently, Kuroda et al. explained the role of prostaglandin E2 
(PGE2), a well-characterized proinflammatory lipid mediator, 
in the adjuvanticity of aluminum salts (108). Specifically, they 
clarified the importance of aluminum salt-induced PGE2 for 
antigen-specific IgE production, rather than IgG1 production. 
This information will be useful to elucidate the mechanistic basis 
of the aggravation effects of nanomaterials on IgE-related aller-
gies upon co-exposure with allergens.
Recently, aluminum salt-induced cell death was reported to 
be an important function of adjuvanticity. Marichal et al. showed 
that DNA molecules released from dying host cells as a func-
tion of aluminum salt-induced innate immune responses act as 
damage-associated molecular patterns (DAMPs) to effectively 
induce adaptive immunity (109). In addition, Miki et al. showed 
that the interaction of apoptotic host cells, induced by aluminum 
salts, with CD300a, an immunoreceptor for phosphatidylser-
ine, was important for the adjuvant effects of aluminum salts 
(110). Although many reports have examined the cytotoxicity 
of nanomaterials, few have shown the effects on the immune 
system of DAMPs and dead cells induced by nanomaterials. 
In this regard, Rabollil et  al. showed that IL-1α from necrotic 
alveolar macrophages was important for SiO2 nanoparticle-
induced lung inflammation (111), although the importance of 
this IL-1α production for the induction of adaptive immunity 
was not clear. Recently, Kuroda et  al. also indicated that IL-1α 
release from alveolar macrophage death induced by aluminum 
salts contribute to adjuvant activity in the lungs (112). Since LPS 
stimulation induce alveolar macrophage death and IL-1α release 
(113), IL-1α release in the lungs seems an important event for 
immune responses in the lung. In addition, Natsuaki et al. showed 
that IL-1α-induced leukocyte clusters is important for efficient 
activation of T cells in skin (114), suggesting the essential immu-
nological role of IL-1α in skin. Cell death might be required for 
allergic responses in the skin, the precise mechanisms involved 
in cell death in skin after exposure to nanomaterials should be 
investigated.
Many reports have shown the seemingly linear relationship 
between the biological effects of nanomaterials and their size. 
However, several in vitro studies have shown that nanomaterials 
with a diameter of 50 nm induce more cellular uptake or cytotox-
icity compared with their larger and smaller counterparts (115, 
116), suggesting the existence of size-specific nanotoxicity. Yet, 
few reports have shown such size-specific effects of nanomateri-
als in vivo. Therefore, further studies are needed to elucidate the 
size-specific immunomodulating mechanisms of nanomaterials, 
which might be different from those of aluminum salts.
FUTURe PROSPeCTS AND CONCLUSiON
It is difficult to judge whether topical application of nanomateri-
als to healthy skin poses a risk for disruption of immune homeo-
stasis, because most nanomaterials cannot penetrate healthy 
skin. On the other hand, there is an urgent need to identify the 
potential of nanomaterials to cause sensitization either directly or 
via co-exposure with substances in people with allergic diseases 
and damaged skin. In this regard, there are many unresolved 
problems.
Recently, new information surfaced regarding the relationship 
between commensal bacteria and the host’s immune system: the 
commensal bacteria on the skin may in fact influence the host’s 
immune system (117, 118). For example, microbial diversity on 
skin is known to be markedly reduced in patients with atopic 
dermatitis, and treatment could restore this diversity (119). 
Therefore, we may need to consider both the direct effects of 
nanomaterials on the microbiota on skin and the indirect effects 
of nanomaterials on host immune systems via changes in the 
diversity and composition of the microbiota on skin. In addi-
tion, most bacteria have pathogen-associated molecular patterns 
(PAMPs), which are ligands of pattern recognition receptors, such 
as Toll-like receptors, Nod-like receptors, RIG-I-like receptors, 
and C-type lectin receptors (120). PAMPs could induce innate 
immunity, mediated by macrophages and dendritic cells, and 
activate innate immunity, such as the production of cytokines and 
chemokines, to induce effective adaptive immunity. Therefore, we 
need in-depth studies of the co-exposure effects of PAMPs and 
nanomaterials, in addition to the effects of DAMPs.
A range of toxicological studies have been conducted assessing 
various physicochemical characteristics of nanomaterials, such 
as particle size, surface charge, surface hydrophobicity, particle 
shape, and states of agglomeration and aggregation. However, the 
results have been inconsistent to date and definitive rules cannot 
yet be established. Systematic information about the relationships 
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among the physicochemical properties and biological effects of 
nanomaterials is still lacking.
Recent studies have revealed that particle-induced immune 
responses are involved in pathological processes of chronic 
inflammation such as allergy. It is not too much to say that the 
skin is the immune sentinel of our tissues. However, the underly-
ing mechanisms of the effects of nanomaterials are not fully 
understood. To establish rules governing the contributions of 
nanomaterials to allergic responses, we need more information, 
including an understanding of the molecular mechanisms of 
action of nanomaterials. These future studies could promote ways 
for us to live in harmony with nanomaterials. Furthermore, such 
studies would provide useful information to improve the safety 
and efficacy of nanomaterials used in skincare.
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